SL Science Holding Limited (SLBT)
NASDAQ: SLBT · Real-Time Price · USD
5.79
-0.59 (-9.25%)
At close: Jun 18, 2026, 4:00 PM EDT
6.00
+0.21 (3.63%)
After-hours: Jun 18, 2026, 7:59 PM EDT
Company Description
SL Science Holding Limited manufactures cosmetic skin care and scalp care products.
The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series.
It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes.
The company is based in Taipei, Taiwan.
SL Science Holding Limited
| Country | Taiwan |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Ching-Dong Wang |
Contact Details
Address: 11 F., No. 479, Chongyang Road Taipei, 115010 Taiwan | |
| Phone | 886 2 2651 6826 |
| Website | sl-bio.com |
Stock Details
| Ticker Symbol | SLBT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Reporting Currency | USD |
| CIK Code | 2070534 |
| ISIN Number | KYG8191L1169 |
Key Executives
| Name | Position |
|---|---|
| Ching-Dong Wang | Chief Executive Officer |
| Ray Leung | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 18, 2026 | SCHEDULE 13D | Filing |
| Jun 18, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Jun 15, 2026 | 6-K | Report of foreign issuer |
| Jun 12, 2026 | CERT | Certification by an exchange approving securities for listing |
| Jun 11, 2026 | 8-A12B | Registration of securities |
| Jan 13, 2026 | EFFECT | Notice of Effectiveness |
| Jan 13, 2026 | 424B3 | Prospectus |
| Jan 7, 2026 | F-4/A | Filing |
| Dec 18, 2025 | F-4 | Filing |
| Nov 14, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |